BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
View Top Employees from BridgeBioWebsite | http://www.bridgebio.com |
Ticker | BBIO |
Funding | $942.3 million |
Employees | 527 (395 on RocketReach) |
Founded | 2014 |
Address | 421 Kipling St, Palo Alto, California 94301, US |
Phone | (650) 391-9740 |
Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare, Business Services |
Keywords | Genetic Testing, Rare Disease, Drug Development And Manufacturing, Pharmaceuticals, Biotechnology, Medicine, Healthcare, Therapeutic Activities, Clinical Trials |
Competitors | Evelo Biosciences, Mirati Therapeutics Inc, MyoKardia, QUEST PHARMA LIMITED, Syros Pharmaceuticals |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular BridgeBio employee's phone or email?
395 people are employed at BridgeBio.
BridgeBio is based in Palo Alto, California.
The NAICS codes for BridgeBio are [325, 3254, 32, 32541].
The SIC codes for BridgeBio are [873, 87].